Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Atfa Sassi is active.

Publication


Featured researches published by Atfa Sassi.


The Journal of Allergy and Clinical Immunology | 2014

Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels

Atfa Sassi; Sandra Lazaroski; Gang Wu; Stuart M. Haslam; Manfred Fliegauf; Fethi Mellouli; Turkan Patiroglu; Ekrem Unal; Mehmet Akif Ozdemir; Zineb Jouhadi; Khadija Khadir; Leila Ben-Khemis; Meriem Ben-Ali; Imen Ben-Mustapha; Lamia Borchani; Dietmar Pfeifer; Thilo Jakob; Monia Khemiri; A. Charlotta Asplund; Manuela O. Gustafsson; Karin E. Lundin; Elin Falk-Sörqvist; Lotte N. Moens; Hatice Eke Gungor; Karin R. Engelhardt; Magdalena Dziadzio; Hans J. Stauss; Bernhard Fleckenstein; Rebecca Meier; Khairunnadiya Prayitno

BACKGROUND Recurrent bacterial and fungal infections, eczema, and increased serum IgE levels characterize patients with the hyper-IgE syndrome (HIES). Known genetic causes for HIES are mutations in signal transducer and activator of transcription 3 (STAT3) and dedicator of cytokinesis 8 (DOCK8), which are involved in signal transduction pathways. However, glycosylation defects have not been described in patients with HIES. One crucial enzyme in the glycosylation pathway is phosphoglucomutase 3 (PGM3), which catalyzes a key step in the synthesis of uridine diphosphate N-acetylglucosamine, which is required for the biosynthesis of N-glycans. OBJECTIVE We sought to elucidate the genetic cause in patients with HIES who do not carry mutations in STAT3 or DOCK8. METHODS After establishing a linkage interval by means of SNPchip genotyping and homozygosity mapping in 2 families with HIES from Tunisia, mutational analysis was performed with selector-based, high-throughput sequencing. Protein expression was analyzed by means of Western blotting, and glycosylation was profiled by using mass spectrometry. RESULTS Mutational analysis of candidate genes in an 11.9-Mb linkage region on chromosome 6 shared by 2 multiplex families identified 2 homozygous mutations in PGM3 that segregated with disease status and followed recessive inheritance. The mutations predict amino acid changes in PGM3 (p.Glu340del and p.Leu83Ser). A third homozygous mutation (p.Asp502Tyr) and the p.Leu83Ser variant were identified in 2 other affected families, respectively. These hypomorphic mutations have an effect on the biosynthetic reactions involving uridine diphosphate N-acetylglucosamine. Glycomic analysis revealed an aberrant glycosylation pattern in leukocytes demonstrated by a reduced level of tri-antennary and tetra-antennary N-glycans. T-cell proliferation and differentiation were impaired in patients. Most patients had developmental delay, and many had psychomotor retardation. CONCLUSION Impairment of PGM3 function leads to a novel primary (inborn) error of development and immunity because biallelic hypomorphic mutations are associated with impaired glycosylation and a hyper-IgE-like phenotype.


Infection and Immunity | 2004

Leishmania major Amastigotes Induce p50/c-Rel NF-κΒ Transcription Factor in Human Macrophages: Involvement in Cytokine Synthesis

Lamia Guizani-Tabbane; Khadija Ben-Aissa; Meriam Belghith; Atfa Sassi; Koussay Dellagi

ABSTRACT Invasion of a host by pathogens is frequently associated with activation of nuclear factor kappa B (NF-κB), which is implicated in various aspects of immune function required for resistance to infection. However, pathogens may also subdue these mechanisms to secure their survival. Here we describe the effect of Leishmania major infection on NF-κB transcription factor activation in both promonocytic human cell line U937 and fresh human monocytes. Infection by L. major amastigotes blocked nuclear translocation of a phorbol-12 myristate-13 acetate (PMA)-induced p50/p65 NF-κB complex in PMA-treated differentiated U937 cells and triggered expression of p50- and c-Rel-containing complexes in both U937 cells and fresh human monocytes. These p50/c-Rel complexes, triggered by direct cell-parasite interactions, were detectable within 30 min after the interaction and were transcriptionally active. The NF-κΒ inhibitor caffeic acid phenethyl ester inhibited production of both tumor necrosis factor alpha and interleukin-10 (IL-10) induced by Leishmania amastigotes in differentiated U937 cells. Similar results for IL-10 induction were observed with amastigote-infected human monocytes. Our results indicate that L. major amastigotes activate NF-κB by specifically inducing p50- and c-Rel-containing complexes which are likely involved in the regulation of cytokine synthesis.


Toxicon | 2011

Heminecrolysin, the first hemolytic dermonecrotic toxin purified from scorpion venom

Lamia Borchani; Atfa Sassi; Delavar Shahbazzadeh; Jean-Marc Strub; Haïfa Tounsi-Guetteti; Mohamed Samir Boubaker; Abolfazl Akbari; Alain Van Dorsselaer; Mohamed El Ayeb

Envenomation caused by Hemiscorpius (H.) lepturus from Liochlidae family presents clinical features that have not been previously described for the Buthidae family scorpions. The most significant manifestations of H. lepturus envenomation are hemolysis and dermonecrosis which could lead in severe cases to renal, cardio-respiratory failure, and death. In this study, we aimed to identify and characterize the protein(s) causing these effects. We have purified a 33 kDa protein from the venom of H. lepturus and named it Heminecrolysin. Tryptic digestion and MS/MS analysis of obtained peptides showed homology with previously described brown spider sphingomyelinases D. Functional characterization of Heminecrolysin indicated a sphingomyelinase D, a complement-dependent hemolysis properties and a dermonecrosis activity. Heminecrolysin displayed higher hemolytic activity to human erythrocytes (ED50 of 0.025 μg/ml), a stronger inflammatory and dermonecrotic effects when injected intra-dermally to rabbit skins, while its efficiency to hydrolyze sphingomyelin seems weaker than other known spider dermonecrotic SMasesD (149 ± 32.5 nmol/mg). Step of sensitization of human erythrocytes by Heminecrolysin was shown to be Mg²⁺ and Ca²⁺-independent while hemolysis step in the presence of complement required both bivalent ions. Heminecrolysin is the first hemolytic dermonecrotic toxin identified in venom other than spiders. Except in spider Loxosceles genus and some pathogenic strains of Corynebacteria, sphingomyelinase D activity is unknown in the animal kingdom.


Journal of Immunology | 2005

Mechanisms of the Natural Reactivity of Lymphocytes from Noninfected Individuals to Membrane-Associated Leishmania infantum Antigens

Atfa Sassi; Beya Larguèche-Darwaz; Alexis Collette; Adrien Six; Dhafer Laouini; Pierre André Cazenave; Koussay Dellagi

Membrane-associated Leishmania Ags (MLA) or soluble Leishmania Ags were used in vitro to stimulate cord blood or PBMC from healthy donors noninfected by Leishmania parasites. MLA, but not soluble Leishmania Ags, constantly induce strong proliferation of cord blood mononuclear cells and PBMC from noninfected individuals. Responding cells are CD3+, CD4+, TCRαβ+, CD45RO+, and CD45RA+ and secrete IFN-γ and IL-10, but not IL-4. MLA do not activate NK cells nor NKT cells. Membrane Ags also induce purified macrophages from noninfected individuals to secrete IL-10 and TNF-α, but have no effect on IL-1α or IL-12 secretion. The effects of MLA are proteinase K-sensitive and resistant to lipid extraction. The lymphoproliferative responses are inhibited by anti-HLA-DR Abs and require Ag processing by APCs, excluding that the biological effect of MLA could be attributed to a superantigen. Finally, TCR repertoire analysis shows that the T cell expansion induced by MLA uses TCR with various variable β segment rearrangements and CDR3 lengths, features much more characteristic to those observed with a polyclonal activator than with a conventional Ag. These results suggest a particular mechanism developed during the host’s natural response to Leishmania parasites that allows direct activation of naive CD4 lymphocytes by parasite membrane-associated Ags.


Parasite Immunology | 2015

Identification of immunodominant Leishmania major antigenic markers of the early C57BL/6 and BALB/c mice infection stages

Atfa Sassi; Olfa Kaak; Amel Benammar Elgaaied

The C57BL/6 mouse strain is resistant to Leishmania (L.) major infection and, unlike susceptible BALB/c, develops small self‐healing cutaneous lesions. The specific antibody responses of C57BL/6 and BALB/c mice were previously characterized by the predominance of IgG2a (‘resistant’ isotype associated with Th1) and IgG1 (‘pathogenic’ isotype associated with Th2) antibodies, respectively. In this study, we looked for the presence of antigens able to elicit an exclusive or predominant IgG1 production during the early stages of C57BL/6 lesion development and checked whether they are recognized or not by BALB/c mice. We demonstrate first that IgG2a predominance in C57BL/6 sera occurs only late after infection, whereas in BALB/c, IgG1 antibodies dominate mostly in the early stages. Interestingly, soon after inoculation of live amastigotes, C57BL/6 displayed an exclusive IgG1 reactivity against particular L. major antigens but with MWs different from those identified in BALB/c. Furthermore, mice immunized with killed amastigotes displayed striking differences in their immunodetection profiles, particularly for the IgG1 isotype. Taken together, the observed differences in the specific antibody repertoires between infected mice resulted, at least in part, from immunological events independent from those triggered by the replicating parasite, and bring new insights into the selection of future vaccine candidates.


The Journal of Allergy and Clinical Immunology | 2015

The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency

Karin R. Engelhardt; Michael E. Gertz; Sevgi Keles; Alejandro A. Schäffer; Elena C. Sigmund; Cristina Glocker; Shiva Saghafi; Zahra Pourpak; R Ceja; Atfa Sassi; L Graham; Michel J. Massaad; Fethi Mellouli; Imen Ben-Mustapha; Monia Khemiri; Sara Sebnem Kilic; Amos Etzioni; Alexandra F. Freeman; Jens Thiel; Ilka Schulze; Waleed Al-Herz; Ayse Metin; Ozden Sanal; Ilhan Tezcan; Mehdi Yeganeh; Tim Niehues; Gregor Dueckers; Sebastian Weinspach; Turkan Patiroglu; Ekrem Unal


Archives De Pediatrie | 1997

Les déficits immunitaires primitifs en Tunisie: étude de 152 cas

Mohamed Bejaoui; Mohamed-Ridha Barbouche; Atfa Sassi; B Larguche; N Miladi; Annie Bouguerra; Koussay Dellagi


Toxicon | 2013

The pathological effects of Heminecrolysin, a dermonecrotic toxin from Hemiscorpius lepturus scorpion venom are mediated through its lysophospholipase D activity.

Lamia Borchani; Atfa Sassi; Haifa Ben Gharsa; Ines Safra; Delavar Shahbazzadeh; Zakaria Ben Lasfar; Mohamed El Ayeb


Toxicon | 2011

Heminecrolysin, a potential immunogen for monospecific antivenom production against Hemiscorpius lepturus scorpion

Lamia Borchani; Atfa Sassi; Ramla Ben Yekhlef; Ines Safra; Mohamed El Ayeb


Veterinary Parasitology | 2018

Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs

Azza Chaabouni; Ramzi Boubaker Elandoulsi; Moez Mhadhbi; Mohamed Gharbi; Atfa Sassi

Collaboration


Dive into the Atfa Sassi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Monia Khemiri

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Sevgi Keles

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Tim Niehues

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Ilka Schulze

University Medical Center Freiburg

View shared research outputs
Top Co-Authors

Avatar

Jens Thiel

University Medical Center Freiburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ayse Metin

Boston Children's Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge